Arizona Biosciences News

TGen receives $100,000 to study rare adrenal gland cancer

The Flinn Foundation
Tags: cancer, tgen

Summary:

The Translational Genomics Research Institute has received a $100,000 gift from Scottsdale philanthropist Troy Richards to support research into a rare cancer of the adrenal cortex.

Full Story:

The Translational Genomics Research Institute has received a $100,000 gift from Scottsdale philanthropist Troy Richards to support research into a rare cancer of the adrenal cortex.

The award will be used to establish the Advancing Treatments for Adrenocortical Carcinoma Fund. Besides committing $100,000 to TGen, Richards also will work with the TGen Foundation to raise additional funds for the project.

TGen researchers will use genomic data to identify mutations and design new diagnostic tools and therapeutics to combat this aggressive cancer, which affects the outer layer of the adrenal glands, located above each kidney in the back of the upper abdomen.

When cells in the adrenal cortex become cancerous, they can overproduce hormones, which cause symptoms such as high blood pressure, weakening of the bones, or diabetes.

There is only one drug currently on the market that is approved to treat the disease. TGen researchers and Richards hope the project will one day offer adrenocortical carcinoma (ACC) patients new and better therapies.

The project is the largest ACC research project to date.


For more information:

"TGen foundation announces new cancer fund," TGen press release, 10/03/2005